Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
GT Biopharma, Inc.Listing on record | BuyD (derivative) | n/a (Converted to USD in the nightly refresh) | First in 12mo | SEC | |
GT Biopharma, Inc.Listing on record | OtherD (derivative) | $35K | SEC | ||
GT Biopharma, Inc.Listing on record | Other | $35K | SEC | ||
GT Biopharma, Inc.Listing on record | Sell | $44.2K | SEC | ||
GT Biopharma, Inc.Listing on record | Sell | $46.8K | SEC |